Erlotinib Completed Phase 2 Trials for Stage III Esophageal Cancer / Recurrent Esophageal Cancer / Squamous Cell Carcinoma of the Esophagus / Adenocarcinoma of the Esophagus / Adenocarcinomas of the Gastroesophageal Junction / Stage IV Esophageal Cancer Treatment